Screening for possible drug carcinogenicity: Second report of findings

Journal of the National Cancer Institute

Volumn 71, Issue 6, 1983, Pages 1165-1175

  Friedman, Gary D ^a   Ury, Hans K ^a  

^a Department of Medical Methods Research ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANALGESIC AGENT; ATROPINE; BARBITURIC ACID DERIVATIVE; CARDIAC GLYCOSIDE; CEFALEXIN; CHLORAMBUCIL; CHLORPROMAZINE; CLOFIBRATE; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DEXTROPROPOXYPHENE; DIURETIC AGENT; DRUG; ERGOTAMINE; ESTROGEN; FLUOCINONIDE; FLUOROURACIL; FLUOXYMESTERONE; FOLIC ACID; FORMALDEHYDE; FUROSEMIDE; HORMONE; IRON; IRON SALT; ISONIAZID; MECLOZINE; OXYTETRACYCLINE; PHENFORMIN; PSEUDOEPHEDRINE; PSYCHOTROPIC AGENT; RAUWOLFIA ALKALOID; THIAZIDE DIURETIC AGENT; TOLBUTAMIDE; TRIFLUOPERAZINE; TRIPROLIDINE;

ADVERSE DRUG REACTION; CARCINOGENESIS; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; DRUG SCREENING; DRUG THERAPY; EPIDEMIOLOGY; FOLLOW UP; HUMAN; REVIEW; SCREENING; THERAPY; ARTICLE; FEMALE; IATROGENIC DISEASE; MALE; MASS SCREENING; METHODOLOGY; NEOPLASM; PRESCRIPTION; TIME; UNITED STATES;

CALIFORNIA; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MASS SCREENING; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0020973085     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/71.6.1165     Document Type: Article

References (18)

1. FRIEDMAN GD, URY HK. Initial screening for carcinogenicity of commonly used drugs. JNCI 1980; 65:723-733.
2. FRIEDMAN GD. Monitoring of drug effects in outpatients: Devel opment of a program to detect carcinogenesis. In: Ducrot H, Goldberg M, Hoigne R, Middleton P, eds. Computer aid to drug therapy and to drug monitoring. Amsterdam: North- Holland Publishing Company, 1978:55-62.
3. FRIEDMAN GD. Barbiturates and lung cancer in humans. INCI 1981; 67:291-295.
4. FRIEDMAN GD. Phenylbutazone, musculoskeletal disease, and leukemia. J Chronic Dis 1982; 35:233-243.
5. HOOVER R, FRAUMENI JF JR. Drugs. In: Fraumeni JF Jr, ed. Persons at high risk of cancer: An approach to cancer etiology and control. New York: Academic Press, 1975:185-199.
6. INNES IR, NICKERSON M. Atropine, scopolamine, and related antimuscarinic drugs. In: Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 5th ed. New York: MacMillan, 1975:514-532.
7. International Agency for Research on Cancer. Antineoplastic and immunosuppressive agents. IARC Monogr Eval Carcinog Risk Chem Man 1981; 26:115-136 and 165-202.
8. Committee of Principal Investigators. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978;40:1069-1118.
9. SWENBERG JA, KERNS WD, MITCHELL RI, GRALLA EJ, PAVKOV KL. Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res 1980;40:3398-3402.
10. FRIEDMAN GD, SIEGELAUB AB, SELTZER CC. Cigarettes, alcohol, coffee, and peptic ulcer. N Engl J Med 1974; 290:469-473.
11. Weinberg ED. Iron and neoplasia. Biol Trace Elem Res 1981; 3:55-80.
12. Stolley PD, Hibbard PL. Drugs. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:304-317.
13. MACK TM. Pancreas. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:638-667.
14. KELSEY JL. A review of the epidemiology of human breast cancer. Epidemiol Rev 1979; 1:74-109.
15. CREECH JL JR, JOHNSON MN. Angiosarcoma of liver in the man ufacture of polvvinvl chloride. J Occup Med 1974; 16:150-151.
16. DUNN OJ. Multiple comparisons among means. J Am Stat Assoc 1961;56:52-64.
17. ARMITAGE P, MCPHERSON CK, ROWE BC. Repeated significance tests on accumulating data. J R Stat Soc (series A) 1969; 132:235-244.
18. CANNER PL. Monitoring treatment differences in long-term clinical trials. Biometrics 1977; 33:603-615.